4d Molecular Therapeutics In shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $435k | 50k | 8.69 |
| 2025-06-30 | $93k | 25k | 3.71 |
| 2025-03-31 | $40k | 13k | 3.23 |
| 2023-09-30 | $349k | 27k | 12.73 |
| 2023-06-30 | $495k | 27k | 18.07 |
| 2023-03-31 | $471k | 27k | 17.19 |
| 2022-12-31 | $942k | 42k | 22.21 |
| 2022-09-30 | $461k | 57k | 8.03 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management